COVID-19 Vax in MS: Lower Response on Certain Medications COVID-19 Vax in MS: Lower Response on Certain Medications
New data on COVID vaccination in MS patients has shown a reduced humoral response in patients treated with certain medications -- including ocrelizumab, rituximab, and fingolimod -- but not others.Medscape Medical News
Source: Medscape Infectious Diseases Headlines - Category: Infectious Diseases Tags: Neurology & Neurosurgery News Source Type: news
More News: Brain | COVID-19 | Gilenya | Infectious Diseases | Neurology | Neurosurgery | Rituxan | Vaccines